Medplus Health Financials

NSE: MEDPLUS | BSE: 543427

₹621.45

₹13.30 (2.19%)

As on 27-Oct-2026IST

Market cap

₹7,456 Cr

Revenue (TTM)

₹7,587 Cr

P/E Ratio

35.3

P/B Ratio

3.7

Div. Yield

0 %

Income Statement (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Operating Revenue	7,587.21	6,892.47	6,136.05	5,624.86	4,557.58	3,779.28
Total Income	7,666.42	6,963.79	6,184.67	5,664.86	4,603.65	3,810.64
Total Expenditure	6,956.12	6,268.09	5,632.59	5,253.56	4,276.21	3,490.40
EBITDA	631.09	624.38	503.47	371.30	281.37	288.88
Depreciation	310.44	282.87	249.84	224.21	181.56	119.36
EBIT	320.65	341.51	253.62	147.08	99.81	169.52
Interest	134.20	137.50	118.95	113.65	98.72	82.94
Other Income	79.21	71.32	48.62	40.01	46.08	31.36
Exceptional Items	--	--	--	--	--	--
Profit before Tax	265.65	275.33	183.29	73.44	47.16	117.94
Provision for Tax	54.66	55.72	33.06	7.87	-2.94	23.23
Profit after Tax	211.00	219.61	150.23	65.58	50.11	94.72
Minority Interest	0.04	0.04	0.09	-0.10	-0.34	1.09
Share of Associate	--	--	--	--	--	--
Consolidated Profit	211.04	219.65	150.32	65.47	49.76	95.80

Liabilities (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Shareholder's Funds	2,068.28	1,975.36	1,740.56	1,577.93	1,491.18	1,417.77
Minority Interest	0.04	-0.71	-0.66	-0.57	-0.68	-0.52
Non-Current Liabilities	1,361.51	1,225.00	991.72	849.44	797.41	647.40
Current Liabilities	768.76	763.90	624.57	574.85	476.58	559.01
Total Liabilities	4,197.83	4,084.80	3,456.02	3,086.64	2,830.30	2,668.61

Assets (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Non-Current Assets	558.11	1,820.29	1,464.69	1,385.18	1,283.77	991.95
Current Assets	2,178.89	2,143.26	1,891.49	1,616.46	1,480.72	1,631.71
Total Assets	4,197.83	4,084.80	3,456.02	3,086.64	2,830.30	2,668.61
Total Debt*	--	--	--	--	--	142.68
Net Current Assets	1,410.13	1,379.36	1,266.92	1,041.62	1,004.14	1,072.70
Contingent Liabilities	--	14.06	13.78	13.78	11.89	11.89

Cashflow (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Cash From Operating Activities	--	495.58	540.43	143.74	90.41	169.89
Cash Flow from Investing Activities	--	-127.72	-317.61	-82.80	429.44	-703.13
Cash from Financing Activities	--	-255.51	-227.98	-198.10	-170.25	440.43
Net Cash Inflow / Outflow	--	112.36	-5.16	-137.17	349.60	-92.81

Financials Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Adjusted EPS (₹)	17.58	18.30	12.56	5.48	4.17	8.03
Cash EPS (₹)	17.57	41.85	33.42	24.24	19.42	17.94
Adjusted Book Value (₹)	166.52	163.87	143.22	129.47	122.44	117.89
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	41.28	45.15	12.02	7.58	14.24
Free Cash Flow per Share (₹)	--	23.34	32.52	-2.15	-12.78	-0.50

Profitability Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
ROCE (%)	--	22.22	18.22	12.19	9.56	16.56
ROE (%)	10.44	11.93	9.21	4.36	3.50	9.07
ROA (%)	5.43	6.00	4.73	2.27	1.86	4.51
EBIT Margin (%)	4.23	4.95	4.13	2.61	2.19	4.49
Net Margin (%)	2.75	3.15	2.43	1.16	1.09	2.49
Cash Profit Margin (%)	--	7.19	6.43	5.08	5.01	5.59

Growth Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Revenue Growth (%)	20.57	12.33	9.09	23.42	20.59	23.13
EBIT Growth (%)	11.48	34.65	72.44	47.36	-41.12	20.27
Net Profit Growth (%)	8.18	46.18	129.09	30.88	-47.10	50.08
EPS Growth (%)	7.93	45.68	129.29	31.32	-48.06	-97.18
Book Value Growth (%)	--	14.76	10.77	5.94	3.87	106.24

Valuation Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Price / Earnings	35.33	45.79	60.48	125.87	156.11	125.80
Price / Book Value	3.73	5.11	5.30	5.33	5.32	8.57
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	10.10	13.79	15.80	19.69	22.86	37.97
Close Price (₹)	654.90	839.90	760.00	687.85	649.70	1,014.50
High Price (₹)	1,022.20	1,052.05	876.75	978.00	1,049.00	1,343.00
Low Price (₹)	645.00	603.00	615.55	597.95	548.25	921.00
Market Cap (₹ Cr)	7,456.31	10,057.49	9,091.18	8,241.54	7,768.39	12,052.28

Solvency Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Debt to Equity	--	--	--	--	--	0.10
Short term debt to equity ratio	--	--	--	--	--	0.10
Current Ratio	2.83	2.81	3.03	2.81	3.11	2.92
Quick Ratio	0.86	1.00	0.87	0.48	0.71	1.28
Interest Coverage	2.98	3.00	2.54	1.65	1.48	2.42

Operating Efficiency Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Debtors to sales (%)	0.51	0.39	0.22	0.31	0.19	0.16
Asset Turnover	1.95	1.91	1.96	1.98	1.72	1.83
Receivable days	--	1.05	0.90	0.84	0.58	0.54
Inventory Days	--	71.25	78.76	79.52	81.27	79.28
Payable days	--	21.75	21.71	21.33	25.98	24.13
Cash Conversion Cycle	--	50.55	57.95	59.03	55.87	55.69

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement (₹ Cr)